Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence.

  • T. K
  • I. K
  • P.I. R
 et al. 
  • 1


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


There is growing universal concern regarding counterfeit medications. In particular, counterfeit antimicrobial drugs are a threat to public health with many devastating consequences for patients; increased mortality and morbidity and emergence of drug resistance. In addition, physicians treating these patients lose their confidence in the medications used and report high levels of bacterial resistance. The problem with fake and suboptimal medications got worse with the advent of the World Wide Web; a significant proportion of medications that are sold through Internet pharmacies is counterfeit. Various initiatives of the WHO (the International Medical Products Anti-Counterfeiting Taskforce) are hopefully going to tackle this very important public health issue. In this article, we review the available evidence in peer-reviewed articles and World Wide Web information resources regarding the issue of counterfeit antimicrobials. © The Author 2007.

Author-supplied keywords

  • *Anti-Bacterial Agents/st [Standards]
  • *antiinfective agent/an [Drug Analysis]
  • *antiinfective agent/pr [Pharmaceutics]
  • *drug quality
  • Anti-Bacterial Agents/pd [Pharmacology]
  • Anti-Bacterial Agents/pk [Pharmacokinetics]
  • Antiparasitic Agents/pd [Pharmacology]
  • Antiparasitic Agents/st [Standards]
  • Antitubercular Agents/pd [Pharmacology]
  • Antitubercular Agents/st [Standards]
  • Antiviral Agents/pd [Pharmacology]
  • Antiviral Agents/st [Standards]
  • Biological Availability
  • Drug Industry/sn [Statistics & Numerical Data]
  • Drug Industry/st [Standards]
  • Drug Resistance
  • Humans
  • Internet
  • Microbial
  • Terminology as Topic
  • amoxicillin/an [Drug Analysis]
  • ampicillin/an [Drug Analysis]
  • ampicillin/pr [Pharmaceutics]
  • antibiotic resistance
  • antimalarial agent/an [Drug Analysis]
  • antimalarial agent/pr [Pharmaceutics]
  • antiparasitic agent/an [Drug Analysis]
  • antivirus agent/an [Drug Analysis]
  • azithromycin/an [Drug Analysis]
  • cefalexin/an [Drug Analysis]
  • cefazolin/an [Drug Analysis]
  • cefotaxime/an [Drug Analysis]
  • cefradine/an [Drug Analysis]
  • ceftazidime/an [Drug Analysis]
  • ceftriaxone/an [Drug Analysis]
  • cephalosporin derivative/an [Drug Analysis]
  • chlortetracycline/an [Drug Analysis]
  • ciprofloxacin/an [Drug Analysis]
  • clarithromycin/an [Drug Analysis]
  • cotrimoxazole/an [Drug Analysis]
  • doxycycline/an [Drug Analysis]
  • drug bioavailability
  • drug formulation
  • drug stability
  • erythromycin/an [Drug Analysis]
  • gentamicin/an [Drug Analysis]
  • good manufacturing practice
  • human
  • macrolide/an [Drug Analysis]
  • metronidazole/an [Drug Analysis]
  • morbidity
  • mortality
  • nalidixic acid/an [Drug Analysis]
  • neomycin/an [Drug Analysis]
  • neomycin/pr [Pharmaceutics]
  • ofloxacin/an [Drug Analysis]
  • peer review
  • pharmacy
  • prevalence
  • public health
  • quantitative analysis
  • review
  • roxithromycin/an [Drug Analysis]
  • tetracycline/an [Drug Analysis]
  • tuberculostatic agent/an [Drug Analysis]
  • unindexed drug
  • world health organization

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Kelesidis T.

  • Kelesidis I.

  • Rafailidis P.I.

  • Falagas M.E.

  • Theodore Kelesidis

  • Iosif Kelesidis

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free